Angiopoietin-2 is a direct transcriptional target of tal1, lyl1 and lmo2 in endothelial cells

PLoS ONE

Volumn 7, Issue 7, 2012, Pages

  Deleuze, Virginie ^a,b   El Hajj, Rawan ^a,b   Chalhoub, Elias ^a,b,d   Dohet, Christiane ^a,b   Pinet, Valérie ^a,b   Couttet, Philippe ^c,e   Mathieu, Danièle ^a,b  

^a INSTITUT DE GÉNÉTIQUE MOLÉCULAIRE DE MONTPELLIER   (France)

^b UNIV MONTPELLIER   (France)

^c WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

^d UNIVERSITY OF BALAMAND   (Lebanon)

^e NOVARTIS PHARMA AG   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOPOIETIN 2; BASIC HELIX LOOP HELIX TRANSCRIPTION FACTOR; FIBROBLAST GROWTH FACTOR 2; INTERLEUKIN 3; LIM ONLY 2 PROTEIN; MESSENGER RNA; SMALL INTERFERING RNA; STEM CELL FACTOR; STROMAL CELL DERIVED FACTOR 1ALPHA; TRANSCRIPTION FACTOR GATA 2; TRANSCRIPTION FACTOR LYL1; TRANSCRIPTION FACTOR TAL1; UNCLASSIFIED DRUG; VASCULOTROPIN;

ANGIOGENESIS; ANGIOPOIETIN 2 GENE; ARTICLE; CELL STRAIN HEK293; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; DIMERIZATION; DOWN REGULATION; EMBRYO; GENE; GENE ACTIVATION; GENE EXPRESSION REGULATION; GENE SILENCING; GENE TARGETING; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MICROVASCULAR ENDOTHELIAL CELL; PROMOTER REGION; PROTEIN DNA BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; UMBILICAL VEIN ENDOTHELIAL CELL; UPREGULATION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANGIOPOIETIN-2; BASE SEQUENCE; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; CONSERVED SEQUENCE; GATA2 TRANSCRIPTION FACTOR; GENE EXPRESSION REGULATION; GENE KNOCKDOWN TECHNIQUES; GENES, REPORTER; HEK293 CELLS; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; LIM DOMAIN PROTEINS; LUCIFERASES, FIREFLY; MICROVESSELS; MOLECULAR SEQUENCE DATA; NEOPLASM PROTEINS; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; PROTEIN MULTIMERIZATION; PROTO-ONCOGENE PROTEINS; RNA, SMALL INTERFERING; TRANSCRIPTION, GENETIC;

EID: 84863707683     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0040484     Document Type: Article

References (55)

1. Herbert SP, Stainier DY, (2011) Molecular control of endothelial cell behaviour during blood vessel morphogenesis. Nat Rev Mol Cell Biol 12: 551-564.
2. Bertrand JY, Chi NC, Santoso B, Teng S, Stainier DY, et al. (2010) Haematopoietic stem cells derive directly from aortic endothelium during development. Nature 464: 108-111.
3. Jaffredo T, Gautier R, Eichmann A, Dieterlen-Lievre F, (1998) Intraaortic hemopoietic cells are derived from endothelial cells during ontogeny. Development 125: 4575-4583.
4. Zovein AC, Hofmann JJ, Lynch M, French WJ, Turlo KA, et al. (2008) Fate tracing reveals the endothelial origin of hematopoietic stem cells. Cell Stem Cell 3: 625-636.
5. Giroux S, Kaushik AL, Capron C, Jalil A, Kelaidi C, et al. (2007) lyl-1 and tal-1/scl, two genes encoding closely related bHLH transcription factors, display highly overlapping expression patterns during cardiovascular and hematopoietic ontogeny. Gene Expr Patterns 7: 215-226.
6. Yamada Y, Warren AJ, Dobson C, Forster A, Pannell R, et al. (1998) The T cell leukemia LIM protein Lmo2 is necessary for adult mouse hematopoiesis. Proc Natl Acad Sci U S A 95: 3890-3895.
7. Lecuyer E, Hoang T, (2004) SCL: from the origin of hematopoiesis to stem cells and leukemia. Exp Hematol 32: 11-24.
8. Visvader JE, Fujiwara Y, Orkin SH, (1998) Unsuspected role for the T-cell leukemia protein SCL/tal-1 in vascular development. Genes Dev 12: 473-479.
9. Porcher C, Liao EC, Fujiwara Y, Zon LI, Orkin SH, (1999) Specification of hematopoietic and vascular development by the bHLH transcription factor SCL without direct DNA binding. Development 126: 4603-4615.
10. Gering M, Yamada Y, Rabbitts TH, Patient RK, (2003) Lmo2 and Scl/Tal1 convert non-axial mesoderm into haemangioblasts which differentiate into endothelial cells in the absence of Gata1. Development 130: 6187-6199.
11. Patterson LJ, Gering M, Patient R, (2005) Scl is required for dorsal aorta as well as blood formation in zebrafish embryos. Blood 105: 3502-3511.
12. Yamada Y, Pannell R, Forster A, Rabbitts TH, (2000) The oncogenic LIM-only transcription factor Lmo2 regulates angiogenesis but not vasculogenesis in mice. Proc Natl Acad Sci U S A 97: 320-324.
13. Deleuze V, Chalhoub E, El-Hajj R, Dohet C, Le Clech M, et al. (2007) TAL-1/SCL and its partners E47 and LMO2 up-regulate VE-cadherin expression in endothelial cells. Mol Cell Biol 27: 2687-2697.
14. Kappel A, Schlaeger TM, Flamme I, Orkin SH, Risau W, et al. (2000) Role of SCL/Tal-1, GATA, and ets transcription factor binding sites for the regulation of flk-1 expression during murine vascular development. Blood 96: 3078-3085.
15. Schlaeger TM, Schuh A, Flitter S, Fisher A, Mikkola H, et al. (2004) Decoding hematopoietic specificity in the helix-loop-helix domain of the transcription factor SCL/Tal-1. Mol Cell Biol 24: 7491-7502.
16. Capron C, Lecluse Y, Kaushik AL, Foudi A, Lacout C, et al. (2006) The SCL relative LYL-1 is required for fetal and adult hematopoietic stem cell function and B-cell differentiation. Blood 107: 4678-4686.
17. Souroullas GP, Salmon JM, Sablitzky F, Curtis DJ, Goodell MA, (2009) Adult hematopoietic stem and progenitor cells require either Lyl1 or Scl for survival. Cell Stem Cell 4: 180-186.
18. Wilson NK, Miranda-Saavedra D, Kinston S, Bonadies N, Foster SD, et al. (2009) The transcriptional program controlled by the stem cell leukemia gene Scl/Tal1 during early embryonic hematopoietic development. Blood 113: 5456-5465.
19. Fujiwara T, O'Geen H, Keles S, Blahnik K, Linnemann AK, et al. (2009) Discovering Hematopoietic Mechanisms through Genome-wide Analysis of GATA Factor Chromatin Occupancy. Mol Cell 36: 667-681.
20. Kassouf MT, Hughes JR, Taylor S, McGowan SJ, Soneji S, et al. (2010) Genome-wide identification of TAL1's functional targets: insights into its mechanisms of action in primary erythroid cells. Genome Res 20: 1064-1083.
21. Wilson NK, Foster SD, Wang X, Knezevic K, Schutte J, et al. (2010) Combinatorial transcriptional control in blood stem/progenitor cells: genome-wide analysis of ten major transcriptional regulators. Cell Stem Cell 7: 532-544.
22. Kallianpur AR, Jordan JE, Brandt SJ, (1994) The SCL/TAL-1 gene is expressed in progenitors of both the hematopoietic and vascular systems during embryogenesis. Blood 83: 1200-1208.
23. Pulford K, Lecointe N, Leroy VK, Jones M, Mathieu MD, et al. (1995) Expression of TAL-1 proteins in human tissues. Blood 85: 675-684.
24. Chetty R, Dada MA, Boshoff CH, Comley MA, Biddolph SC, et al. (1997) TAL-1 protein expression in vascular lesions. J Pathol 181: 311-315.
25. Tang T, Shi Y, Opalenik SR, Brantley-Sieders DM, Chen J, et al. (2006) Expression of the TAL1/SCL transcription factor in physiological and pathological vascular processes. J Pathol 210: 121-129.
26. Pirot N, Deleuze V, El-Hajj R, Dohet C, Sablitzky F, et al. (2010) LYL1 activity is required for the maturation of newly formed blood vessels in adulthood. Blood 115: 5270-5279.
27. Lazrak M, Deleuze V, Noel D, Haouzi D, Chalhoub E, et al. (2004) The bHLH TAL-1/SCL regulates endothelial cell migration and morphogenesis. J Cell Sci 117: 1161-1171.
28. Yamada Y, Pannell R, Forster A, Rabbitts TH, (2002) The LIM-domain protein Lmo2 is a key regulator of tumour angiogenesis: a new anti-angiogenesis drug target. Oncogene 21: 1309-1315.
29. Gratzinger D, Zhao S, West R, Rouse RV, Vogel H, et al. (2009) The transcription factor LMO2 is a robust marker of vascular endothelium and vascular neoplasms and selected other entities. Am J Clin Pathol 131: 264-278.
30. Meier N, Krpic S, Rodriguez P, Strouboulis J, Monti M, et al. (2006) Novel binding partners of Ldb1 are required for haematopoietic development. Development 133: 4913-4923.
31. Ades EW, Candal FJ, Swerlick RA, George VG, Summers S, et al. (1992) HMEC-1: establishment of an immortalized human microvascular endothelial cell line. J Invest Dermatol 99: 683-690.
32. Koh W, Stratman AN, Sacharidou A, Davis GE, (2008) In vitro three dimensional collagen matrix models of endothelial lumen formation during vasculogenesis and angiogenesis. Methods Enzymol 443: 83-101.
33. Augustin HG, Koh GY, Thurston G, Alitalo K, (2009) Control of vascular morphogenesis and homeostasis through the angiopoietin-Tie system. Nat Rev Mol Cell Biol 10: 165-177.
34. Fiedler U, Scharpfenecker M, Koidl S, Hegen A, Grunow V, et al. (2004) The Tie-2 ligand angiopoietin-2 is stored in and rapidly released upon stimulation from endothelial cell Weibel-Palade bodies. Blood 103: 4150-4156.
35. Jang C, Koh YJ, Lim NK, Kang HJ, Kim DH, et al. (2009) Angiopoietin-2 exocytosis is stimulated by sphingosine-1-phosphate in human blood and lymphatic endothelial cells. Arterioscler Thromb Vasc Biol 29: 401-407.
36. Simon MP, Tournaire R, Pouyssegur J, (2008) The angiopoietin-2 gene of endothelial cells is up-regulated in hypoxia by a HIF binding site located in its first intron and by the central factors GATA-2 and Ets-1. J Cell Physiol 217: 809-818.
37. Hsu HL, Huang L, Tsan JT, Funk W, Wright WE, et al. (1994) Preferred sequences for DNA recognition by the TAL1 helix-loop-helix proteins. Mol Cell Biol 14: 1256-1265.
38. Miyamoto A, Cui X, Naumovski L, Cleary ML, (1996) Helix-loop-helix proteins LYL1 and E2a form heterodimeric complexes with distinctive DNA-binding properties in hematolymphoid cells. Mol Cell Biol 16: 2394-2401.
39. Lecuyer E, Lariviere S, Sincennes MC, Haman A, Lahlil R, et al. (2007) Protein stability and transcription factor complex assembly determined by the SCL-LMO2 interaction. J Biol Chem 282: 33649-33658.
40. Stratman AN, Davis MJ, Davis GE, (2011) VEGF and FGF prime vascular tube morphogenesis and sprouting directed by hematopoietic stem cell cytokines. Blood 117: 3709-3719.
41. Hegen A, Koidl S, Weindel K, Marme D, Augustin HG, et al. (2004) Expression of angiopoietin-2 in endothelial cells is controlled by positive and negative regulatory promoter elements. Arterioscler Thromb Vasc Biol 24: 1803-1809.
42. Pichiule P, Chavez JC, LaManna JC, (2004) Hypoxic regulation of angiopoietin-2 expression in endothelial cells. J Biol Chem 279: 12171-12180.
43. Daly C, Pasnikowski E, Burova E, Wong V, Aldrich TH, et al. (2006) Angiopoietin-2 functions as an autocrine protective factor in stressed endothelial cells. Proc Natl Acad Sci U S A 103: 15491-15496.
44. Yao D, Taguchi T, Matsumura T, Pestell R, Edelstein D, et al. (2007) High glucose increases angiopoietin-2 transcription in microvascular endothelial cells through methylglyoxal modification of mSin3A. J Biol Chem 282: 31038-31045.
45. Kassouf MT, Chagraoui H, Vyas P, Porcher C, (2008) Differential use of SCL/TAL-1 DNA-binding domain in developmental hematopoiesis. Blood 112: 1056-1067.
46. Wozniak RJ, Keles S, Lugus JJ, Young KH, Boyer ME, et al. (2008) Molecular hallmarks of endogenous chromatin complexes containing master regulators of hematopoiesis. Mol Cell Biol 28: 6681-6694.
47. Tripic T, Deng W, Cheng Y, Zhang Y, Vakoc CR, et al. (2009) SCL and associated proteins distinguish active from repressive GATA transcription factor complexes. Blood 113: 2191-2201.
48. Kanki Y, Kohro T, Jiang S, Tsutsumi S, Mimura I, et al. (2011) Epigenetically coordinated GATA2 binding is necessary for endothelium-specific endomucin expression. Embo J 30: 2582-2595.
49. Linnemann AK, O'Geen H, Keles S, Farnham PJ, Bresnick EH, (2011) Genetic framework for GATA factor function in vascular biology. Proc Natl Acad Sci U S A 108: 13641-13646.
50. Bresnick EH, Katsumura KR, Lee HY, Johnson KD, Perkins AS, (2012) Master regulatory GATA transcription factors: mechanistic principles and emerging links to hematologic malignancies. Nucleic Acids Res.
51. El Omari K, Hoosdally SJ, Tuladhar K, Karia D, Vyas P, et al. (2011) Structure of the leukemia oncogene LMO2: implications for the assembly of a hematopoietic transcription factor complex. Blood 117: 2146-2156.
52. Dejana E, Tournier-Lasserve E, Weinstein BM, (2009) The control of vascular integrity by endothelial cell junctions: molecular basis and pathological implications. Dev Cell 16: 209-221.
53. Coffelt SB, Tal AO, Scholz A, De Palma M, Patel S, et al. (2010) Angiopoietin-2 Regulates Gene Expression in TIE2-Expressing Monocytes and Augments Their Inherent Proangiogenic Functions. Cancer Res 70.
54. Lewis CE, Ferrara N, (2011) Multiple effects of angiopoietin-2 blockade on tumors. Cancer Cell 19: 431-433.
55. Mazzieri R, Pucci F, Moi D, Zonari E, Ranghetti A, et al. (2011) Targeting the ANG2/TIE2 axis inhibits tumor growth and metastasis by impairing angiogenesis and disabling rebounds of proangiogenic myeloid cells. Cancer Cell 19: 512-526.